logo.jpg
Tobemstomig Clinical Trials Bispecific Antibodies Market Clinical Trials Drug Sales Market Forecast 2029
March 17, 2024 13:28 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Plamotamab Clinical Trials Global Bispecific Antibodies Market Drug Sales Report 2029
March 17, 2024 13:23 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Pidilizumab Clinical Trials Bispecific Antibodies Market Report 2029
March 17, 2024 13:09 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Navicixizumab Clinical Trials Bispecific Antibodies Market Size Drug Sales Insight
March 17, 2024 13:08 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Lomvastomig Clinical Trials Bispecific Antibodies Market Clinical Pipeline Insight
March 17, 2024 12:38 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Imvotamab Clinical Trials Bispecific Antibodies Market Growth Outlook
March 17, 2024 12:35 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
logo.jpg
Acimtamig Clinical Trial Bispecific Antibodies Market Insight 2029
March 17, 2024 12:11 ET | KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
MacroGenics-Logo-(transparent-background).png
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
March 07, 2024 16:01 ET | MacroGenics, Inc.
Presentation of preliminary data from TAMARACK Phase 2 study of vobra duo in mCRPC patients expected at ASCO 2024Initiation of Phase 1 study of MGC026, MacroGenics' first topoisomerase I...
Compass-logo-RGB-outlines.png
Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical Trial
February 28, 2024 08:00 ET | Compass Therapeutics
CTX-8371, a bispecific checkpoint inhibitor that simultaneously targets PD-1 and PD-L1, exhibits a novel mechanism-of-action leading to proteolytic cleavage and subsequent loss of cell surface...
Emergen logo.png
Cancer Biological Therapy Market Size Worth USD 211.23 Billion in 2032 | Emergen Research
January 03, 2024 08:24 ET | Emergen Research
Vancouver, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The global cancer biological therapy market reached USD 99.00 Billion in 2022, expected to grow at a rapid CAGR of 8.0% during the forecast period....